- EBITDA pre exceptionals rose 31.7% to EUR 133 million in Q1 2025.
- Sales stable at EUR 1.601 billion despite lower prices.
- Net income improved to minus EUR 57 million from minus EUR 98 million.
- Urethane Systems sold to UBE Corporation; proceeds to reduce debt.
Financial Performance
In Q1 2025, LANXESS achieved a 31.7% increase in EBITDA pre exceptionals, reaching EUR 133 million, despite a challenging global economic environment. Sales remained stable at EUR 1.601 billion, slightly down from EUR 1.607 billion the previous year, with increased sales volumes offset by lower prices.
Net Income and Guidance
Net income improved to minus EUR 57 million from minus EUR 98 million in the same period last year. The company confirmed its full-year guidance, expecting EBITDA pre exceptionals between EUR 600 and 650 million. For Q2 2025, LANXESS anticipates higher earnings compared to Q1, though lower than the same quarter last year due to the exclusion of Urethane Systems' earnings.
Portfolio Transformation
On April 1, 2025, LANXESS completed the sale of its Urethane Systems business to Japan's UBE Corporation, marking the final step in its shift towards specialty chemicals. The proceeds will be used to redeem a EUR 500 million bond due in May 2025 and reduce debt.
Segment Performance
The Consumer Protection segment saw a 0.8% sales increase to EUR 513 million, with EBITDA pre exceptionals rising 49% to EUR 73 million. Specialty Additives sales fell 3.7% to EUR 545 million, but EBITDA pre exceptionals grew 8.3% to EUR 52 million. Advanced Intermediates sales rose 2.4% to EUR 476 million, with EBITDA pre exceptionals up 8.1% to EUR 40 million. Cost savings from the “FORWARD!” action plan and improved capacity utilization contributed positively across segments.
